Havranek, B., Loh, R., Torre, B., Redfield, R., Halegoua-DeMarzio, D. (2025). Glucagon-like peptide-1 receptor agonists improve metabolic dysfunction-associated steatotic liver disease outcomes. Scientific Reports. https://doi.org/10.1038/s41598-025-89408-z